8 withdrawn. 8 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Withdrawn 8 |
| Phase 1 | 1 | Withdrawn 1 |
Follow Aneurysm: new trials by email Literature Review of Aneurysm trials Research Report on Aneurysm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Targeted PET/CT and PET/MRI Imaging of Vascular Inflammation 18F-FPPRGD2, Positron emission tomography, Computed tomography - Aortic Aneurysm, Abdominal, Carotid Atherosclerosis | Phase 2 | Withdrawn | Stanford University | 2019-10-01 | 2021-05-21 | |
| Study of Efficacy and Safety of Canakinumab in Pediatric Patients With Kawasaki Disease Canakinumab - Kawasaki Disease | Phase 2 | Withdrawn | Novartis Pharmaceuticals | 2016-11-15 | 2017-02-17 | |
| Effect of Intraventricular tPA Following Aneurysmal Subarachnoid Hemorrhage Tissue Plasminogen Activator - Subarachnoid Hemorrhage, Cerebral Vasospasm | Phase 1 / Phase 2 | Withdrawn | Rush University Medical Center | 2015-03-01 | 2015-11-11 | |
| Clevidipine for Vasospasm After Subarachnoid Hemorrhage (SAH) clevidipine - Subarachnoid Hemorrhage, Cerebral Aneurysm | Phase 2 | Withdrawn | Henry Ford Health System | 2014-03-01 | 2023-02-01 | |
| Estrogen Therapy as Prevention in the Progression of Aneurysm (EPPA) Trial Estradiol, Placebo - Cerebral Aneurysm, Menopause | Phase 2 | Withdrawn | Rush University Medical Center | 2013-04-01 | 2021-01-05 | |
| Sildenafil for Prevention of Cerebral Vasospasm Placebo, Sildenafil Citrate, 25 mg, 3 times a day., Sildenafil Citrate 50 mg, 3 times a day - Subarachnoid Hemorrhage, Cerebral Vasospasm | Phase 2 | Withdrawn | Hospital de Clinicas de Porto Alegre | 2010-03-01 | 2015-03-25 | |
| Safety Study of Sildenafil in Treatment of Cerebral Aneurysm Vasospasm Sildenafil citrate - Cerebral Vasospasm, Subarachnoid Hemorrhage | Phase 2 | Withdrawn | University of Nebraska | 2008-07-01 | 2023-08-15 | |
| The Boston Scientific ENOVUS Trial Boston Scientific ENOVUS AAA Endograft - Abdominal Aortic Aneurysm | Phase 2 | Withdrawn | Boston Scientific Corporation | 2015-08-31 |
Intracranial Aneurysm (4) · Subarachnoid Hemorrhage (4) · Vasospasm, Intracranial (4) · Aortic Aneurysm, Abdominal (2) · Aortic Aneurysm (1) · Atherosclerosis (1) · Carotid Artery Diseases (1) · Carotid Stenosis (1) · Coronary Aneurysm (1) · Hydrocephalus (1) · Inflammation (1) · Mucocutaneous Lymph Node Syndrome (1)
Cardiovascular Diseases (8) · Vascular Diseases (8) · Brain Diseases (6) · Central Nervous System Diseases (6) · Cerebrovascular Disorders (6) · Nervous System Diseases (6) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Hemorrhage (4) · Intracranial Arterial Diseases (4) · Intracranial Hemorrhages (4) · Aortic Diseases (2) · Aortic Aneurysm (1) · Arterial Occlusive Diseases (1)
Sildenafil Citrate (2) · Estradiol (1) · FPP(RGD)2 (1) · Magnetic Resonance Imaging (1) · Positron-Emission Tomography (1) · Tissue Plasminogen Activator (1) · Tomography, Emission-Computed (1) · canakinumab (1) · clevidipine (1)
Rush University Medical Center (2) · Boston Scientific Corporation (1) · Henry Ford Health System (1) · Hospital de Clinicas de Porto Alegre (1) · Novartis Pharmaceuticals (1) · Stanford University (1) · University of Nebraska (1)
United States (4) · Brazil (1)
Atahualpa Caue Strapasson, MD (1) · Barbara Soltes, MD (1) · Fabiane Backes, MD (1) · Guy A Music, MD (1) · Mateus Lasta Beck, MD (1) · Michael Chen, MD (1) · Michael V. McConnell, MD, MSEE (1) · Mohammed Rehman, DO (1) · Panayiots Varelas, MD, PhD (1) · Rodney A. White, MD; Chief, Vascular Surgery (1) · Roham Moftakhar, MD (1)